Skip to main content
. 2012 Oct 19;55(22):10229–10240. doi: 10.1021/jm3012933

Figure 1.

Figure 1

Structures of the intravenous, clinical candidate checkpoint kinase inhibitors LY2603618 (1), PF00477736 (2), AZD7762 (3), SCH900776 (4), and LY2606368 (5).